IO102-IO103, KEYTRUDA 25 mg/mL concentrate for solution for infusion
IOB-022/KN-D38
Phase 2 small_molecule active
Quick answer
IO102-IO103, KEYTRUDA 25 mg/mL concentrate for solution for infusion for Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN), Metastatic Urothelial Bladder Cancer (mUBC), Metastatic Non-Small Cell Lung Cancer (NSCLC) is a Phase 2 program (small_molecule) at IO Biotech with 1 ClinicalTrials.gov record(s).
Program details
- Company
- IO Biotech
- Indication
- Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN), Metastatic Urothelial Bladder Cancer (mUBC), Metastatic Non-Small Cell Lung Cancer (NSCLC)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active